Search research articles
Contact Us
Filters
Showing results (261-270 of 309) with videos related to
Page
of 31
Sort By:
Acta Neuropathologica Communications
|
May 9, 2025
Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis
Mais Alsousli, Cecile L Maire, Andras Piffko, et al.
Neuro-Oncology
|
May 13, 2022
Diagnostic potential of extracellular vesicles in meningioma patients
Franz L Ricklefs, Cecile L Maire, Kathrin Wollmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Plos One
|
August 3, 2018
Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature
Katja Engel, Torge Huckhagel, Alessandro Gulberti, et al.
Acta Neuropathologica
|
March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
Marian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Oncotarget
|
May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients
Andreas Mock, Rolf Warta, Christoph Geisenberger, et al.
Acta Neuropathologica Communications
|
March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
Catharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Journal of Neuro-Oncology
|
July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patients
Sabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
Acta Neuropathologica
|
October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells
Catharina Lotsch, Rolf Warta, Fang Liu, et al.
Journal of Neuro-Oncology
|
December 1, 2025
Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma
Alice Ryba, Theresa Mohme, Johannes Kerschbaumer, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 309) with videos related to
Sort By:
Page
of 31
Acta Neuropathologica Communications
|
May 9, 2025
Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis
Mais Alsousli, Cecile L Maire, Andras Piffko, et al.
Neuro-Oncology
|
May 13, 2022
Diagnostic potential of extracellular vesicles in meningioma patients
Franz L Ricklefs, Cecile L Maire, Kathrin Wollmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Plos One
|
August 3, 2018
Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature
Katja Engel, Torge Huckhagel, Alessandro Gulberti, et al.
Acta Neuropathologica
|
March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
Marian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Oncotarget
|
May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients
Andreas Mock, Rolf Warta, Christoph Geisenberger, et al.
Acta Neuropathologica Communications
|
March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas
Catharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Journal of Neuro-Oncology
|
July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patients
Sabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
Acta Neuropathologica
|
October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells
Catharina Lotsch, Rolf Warta, Fang Liu, et al.
Journal of Neuro-Oncology
|
December 1, 2025
Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma
Alice Ryba, Theresa Mohme, Johannes Kerschbaumer, et al.
Page
of 31